Skip to main content

PQ Group sells Performance Materials to Jordan

PQ Group Holdings has agreed to sell its Performance Materials business, known as Potters Industries and a major producer of engineered glass materials, for $650 million to mid-market private equity firm Jordan Company. The deal should close by the end of the year, subject to regulatory approvals and customary closing conditions.

ReSolute project launched

ReSolute, which is described as a “flagship EU project focused on creating a new, sustainably-sourced, safer alternative to traditional, fossil-based solvents”, officially launched on 15 October. Engineering work on its planned 1,000 tonnes/year levoglucosenone (LGO) plant somewhere in Eastern Europe begins in November, with commissioning expected at the end of 2022.

ReSolute project launched

ReSolute, which is described as a “flagship EU project focused on creating a new, sustainably-sourced, safer alternative to traditional, fossil-based solvents”, officially launched on 15 October. Engineering work on its planned 1,000 tonnes/year levoglucosenone (LGO) plant somewhere in Eastern Europe begins in November, with commissioning expected at the end of 2022.

Roquette Beauté Expertise Centre announced

Plant-based ingredients firm Roquette has announced that its first expertise centre in the field of cosmetics will start operating in November. The company said that this is “an important milestone in Roquette Beauté’s development strategy and willingness to be recognised as the B2B expert in plant-based ingredients for cosmetics for the years to come”.

Ardian takes Angus Chemical stake

US private equity giant Ardian has acquired a 50% stake in Angus Chemical from Golden Gate Capital at a total enterprise value of about $2.25 billion. Golden Gate, which bought the firm from Dow Chemical in February 2015, will retain the other. The deal should close at the end of the year.

Siegfried to buy two Novartis sites

Siegfried has agreed to buy two drug product sites near Barcelona, Spain, from Novartis, in a deal expected to close by the end of 2020. Terms were not disclosed but Siegfried said that its sales should surpass CHF 1 billion in 2021, with the drug product operations “achieving the targeted critical size”.

Sterling acquires US facility from Alcami

Pharmaceutical CDMO Sterling Pharma Solutions which is based near Newcastle-upon-Tyne, UK, and was formerly owned by Rhodia and Shasun, has acquired Alcami’s facility at Germantown, Wisconsin (pictured). Terms were not disclosed.

Sterling said that this will boost its API development and manufacturing capacity, particularly for complex and hazardous requirements, and including high potency. Germantown has cGMP development, scale-up and manufacturing facilities with specialist expertise in handling technologies including plant-scale hydrogenation and cryogenic reactions.

Subscribe to Current issue

 

 

 

AMRI banner advert